aVenture · Jun 2026
Recent company-research page summarizing Biocartesian’s product, HQ, and most recent funding profile.
Converting biology into digital molecular maps
Company research
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Overview
Biocartesian is a YC-backed functional genomics company that uses microscopy-native optical pooled screens (ARADIA) to convert biological specimens into digital molecular maps for discovery teams. Public profiles disagree on headquarters (San Francisco vs. Philadelphia), but the company is active and small.
Primary product
ARADIA™ optical pooled screening and digital molecular map generation service
Founded
2023
Headquarters
San Francisco, California, United States
Team size
1-10 employees
Industry
Biotechnology Research
Sub-industry
Functional genomics / spatial biology / microscopy-native pooled screening
Offices
Open Positions
0 jobs at Biocartesian
No open positions
Check back later for new openings